Skip to content
Ubiquitin Ligase-ubiquitin-ligase.com
  • Home
  • About US
  • Search Search

Ubiquitin Ligase-ubiquitin-ligase.com

Post Categories Uncategorized
Post dateNovember 10, 2024Post last updated dateUpdated November 10, 2024

Anti-CSF2 / GM-CSF Reference Antibody (namilumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-CSF2 / GM-CSF Reference Antibody (namilumab)synonym : null,productDescription : Anti-CSF2 /...
Post Categories Uncategorized
Post dateNovember 10, 2024Post last updated dateUpdated November 10, 2024

Anti-CSF2 / GM-CSF Reference Antibody (lenzilumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-CSF2 / GM-CSF Reference Antibody (lenzilumab)synonym : null,productDescription : Anti-CSF2 /...
Post Categories Uncategorized
Post dateNovember 9, 2024Post last updated dateUpdated November 9, 2024

Anti-CSF2 / GM-CSF Reference Antibody (gimsilumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-CSF2 / GM-CSF Reference Antibody (gimsilumab)synonym : productDescription : Anti-CSF2 /...
Post Categories Uncategorized
Post dateNovember 9, 2024Post last updated dateUpdated November 9, 2024

Anti-CSF1R / M-CSFR / CD115 Reference Antibody (LY3022855)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-CSF1R / M-CSFR / CD115 Reference Antibody (LY3022855)synonym : null,productDescription :...
Post Categories Uncategorized
Post dateNovember 8, 2024Post last updated dateUpdated November 8, 2024

Anti-CSF1R / M-CSFR / CD115 Reference Antibody (emactuzumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-CSF1R / M-CSFR / CD115 Reference Antibody (emactuzumab)synonym : null,productDescription :...
Post Categories Uncategorized
Post dateNovember 8, 2024Post last updated dateUpdated November 8, 2024

Anti-TNFSF2 / TNFa Reference Antibody (Epitomics patent anti-TNFα)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-TNFSF2 / TNFa Reference Antibody (Epitomics patent anti-TNFα)synonym : null,productDescription :...
Post Categories Uncategorized
Post dateNovember 7, 2024Post last updated dateUpdated November 7, 2024

Anti-Complement Factor D Reference Antibody (lampalizumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-Complement Factor D Reference Antibody (lampalizumab)synonym : null,productDescription : Anti-Complement Factor...
Post Categories Uncategorized
Post dateNovember 7, 2024Post last updated dateUpdated November 7, 2024

Anti-Complement C5aR1 Reference Antibody (G2 patent anti-C5aR)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-Complement C5aR1 Reference Antibody (G2 patent anti-C5aR)synonym : null,productDescription : Anti-Complement...
Post Categories Uncategorized
Post dateNovember 6, 2024Post last updated dateUpdated November 6, 2024

Anti-DLL4 Reference Antibody (enoticumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-DLL4 Reference Antibody (enoticumab)synonym : null,productDescription : Anti-DLL4 Reference Antibody (enoticumab)(CHA749)...
Post Categories Uncategorized
Post dateNovember 6, 2024Post last updated dateUpdated November 6, 2024

Anti-ANO1 / TMEM16ARabbit mAb

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time51 sec read
Product Name : Anti-ANO1 / TMEM16ARabbit mAbsynonym : null,productDescription : NonemolecularWeight : 114endotoxin :...

Posts navigation

« 1 … 31 32 33 34 35 … 822 »

Recent Posts

  • protein tyrosine phosphatase, receptor type, F
  • FYB201
  • proteasome (prosome, macropain) subunit, beta type, 4
  • KN053
  • phosphoribosyl pyrophosphate synthetase 1

Recent Comments

    Archives

    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Designed by Nasio Themes || Powered by WordPress